• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病与心房颤动之间的关联:一项系统评价和荟萃分析

Link Between Non-Alcoholic Fatty Liver Disease and Atrial Fibrillation: A Systematic Review and Meta-Analysis.

作者信息

Minhas Abdul M, Usman Muhammad Shariq, Khan Muhammad S, Fatima Kaneez, Mangi Muhammad A, Illovsky Michael A

机构信息

GME Internal Medicine, Orange Park Medical Center.

Medical Student, Dow Medical College Karachi, Pakistan.

出版信息

Cureus. 2017 Apr 6;9(4):e1142. doi: 10.7759/cureus.1142.

DOI:10.7759/cureus.1142
PMID:28484681
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5419817/
Abstract

Association between non-alcoholic fatty liver disease (NAFLD) and various cardiovascular diseases has been demonstrated previously. Recent clinical studies have shown that increased circulating levels of γ glutamyl transpeptidase and liver transaminase, markers which are elevated in NAFLD, increase the risk of new-onset atrial fibrillation. We conducted a systematic review and meta-analysis of the available evidence to establish the possible association of increased chances of atrial fibrillation in patients with NAFLD. We extensively searched the PubMed, EMBASE, Cochrane Library, ISI Web of Science and Scopus databases to identify all possible studies that investigated the possible association of NAFLD with atrial fibrillation. Random effect models were used to pool the data between NAFLD and non-NAFLD group. I testing was done to assess the heterogeneity of the included studies. Our primary outcome was atrial fibrillation. A total of three studies including 1044 patients in the NAFLD arm and 1016 in the placebo arm were included. On pooled analysis, it was observed that patients with NAFLD had 2.5 times significantly higher chance (OR = 2.47, CI = 1.30-4.66, p = 0.005) of developing new-onset atrial fibrillation. Our meta-analysis identifies the paucity of high-quality evidence regarding the association between NAFLD and atrial fibrillation. More studies are needed to confirm the link between NAFLD and atrial fibrillation.

摘要

非酒精性脂肪性肝病(NAFLD)与各种心血管疾病之间的关联此前已得到证实。最近的临床研究表明,γ-谷氨酰转肽酶和肝转氨酶的循环水平升高,这些在NAFLD中升高的标志物会增加新发心房颤动的风险。我们对现有证据进行了系统评价和荟萃分析,以确定NAFLD患者发生心房颤动几率增加的可能关联。我们广泛检索了PubMed、EMBASE、Cochrane图书馆、ISI科学网和Scopus数据库,以识别所有调查NAFLD与心房颤动可能关联的研究。采用随机效应模型汇总NAFLD组和非NAFLD组的数据。进行I检验以评估纳入研究的异质性。我们的主要结局是心房颤动。共纳入三项研究,NAFLD组有1044例患者,安慰剂组有1016例患者。汇总分析显示,NAFLD患者发生新发心房颤动的几率显著高出2.5倍(OR = 2.47,CI = 1.30 - 4.66,p = 0.005)。我们的荟萃分析发现,关于NAFLD与心房颤动之间关联的高质量证据不足。需要更多研究来证实NAFLD与心房颤动之间的联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b075/5419817/e3d236407a16/cureus-0009-00000001142-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b075/5419817/ef498ece81a1/cureus-0009-00000001142-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b075/5419817/5920cdc35858/cureus-0009-00000001142-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b075/5419817/e3d236407a16/cureus-0009-00000001142-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b075/5419817/ef498ece81a1/cureus-0009-00000001142-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b075/5419817/5920cdc35858/cureus-0009-00000001142-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b075/5419817/e3d236407a16/cureus-0009-00000001142-i03.jpg

相似文献

1
Link Between Non-Alcoholic Fatty Liver Disease and Atrial Fibrillation: A Systematic Review and Meta-Analysis.非酒精性脂肪性肝病与心房颤动之间的关联:一项系统评价和荟萃分析
Cureus. 2017 Apr 6;9(4):e1142. doi: 10.7759/cureus.1142.
2
The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis.非酒精性脂肪性肝病与心房颤动之间的关联:一项荟萃分析。
Clin Res Hepatol Gastroenterol. 2017 Oct;41(5):525-532. doi: 10.1016/j.clinre.2017.08.001. Epub 2017 Aug 31.
3
A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation.一项基于队列研究的 NAFLD/MAFLD 与新发心房颤动风险的系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2023 Jul 5;14:1160532. doi: 10.3389/fendo.2023.1160532. eCollection 2023.
4
Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.非酒精性脂肪性肝病相关的心血管发病率和死亡率:一项系统评价和荟萃分析。
Curr Probl Cardiol. 2023 Jun;48(6):101643. doi: 10.1016/j.cpcardiol.2023.101643. Epub 2023 Feb 10.
5
Relationship between non-alcoholic fatty liver disease and cardiac arrhythmia: a systematic review and meta-analysis.非酒精性脂肪性肝病与心律失常的关系:系统评价和荟萃分析。
J Int Med Res. 2021 Sep;49(9):3000605211047074. doi: 10.1177/03000605211047074.
6
Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.非酒精性脂肪性肝病患者心血管事件风险:系统评价和荟萃分析。
Eur J Prev Cardiol. 2022 May 6;29(6):938-946. doi: 10.1093/eurjpc/zwab212.
7
Non-alcoholic fatty liver disease increases the risk of cardiovascular disease in young adults and children: a systematic review and meta-analysis of cohort studies.非酒精性脂肪性肝病增加年轻人和儿童患心血管疾病的风险:队列研究的系统评价和荟萃分析
Front Cardiovasc Med. 2024 Jan 10;10:1291438. doi: 10.3389/fcvm.2023.1291438. eCollection 2023.
8
Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis.非酒精性脂肪性肝病与成人心房颤动风险的相关性:一项更新的荟萃分析。
Liver Int. 2019 Apr;39(4):758-769. doi: 10.1111/liv.14044. Epub 2019 Feb 7.
9
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.用于非酒精性脂肪性肝病和非酒精性脂肪性肝炎的他汀类药物。
Cochrane Database Syst Rev. 2013 Dec 27;2013(12):CD008623. doi: 10.1002/14651858.CD008623.pub2.
10
Association between nonalcoholic fatty liver disease and atrial fibrillation and other clinical outcomes: a meta-analysis.非酒精性脂肪性肝病与心房颤动及其他临床结局的相关性:一项荟萃分析。
J Investig Med. 2023 Aug;71(6):591-602. doi: 10.1177/10815589231164777. Epub 2023 Mar 31.

引用本文的文献

1
A Mendelian randomization study reveals a causal association between NASH and the risk of atrial fibrillation.一项孟德尔随机化研究揭示了非酒精性脂肪性肝炎与心房颤动风险之间的因果关联。
Front Endocrinol (Lausanne). 2025 Mar 18;16:1390259. doi: 10.3389/fendo.2025.1390259. eCollection 2025.
2
Exploring Anti-Inflammatory Treatment as Upstream Therapy in the Management of Atrial Fibrillation.探索抗炎治疗作为心房颤动管理中的上游疗法
J Clin Med. 2025 Jan 29;14(3):882. doi: 10.3390/jcm14030882.
3
Increased inter-atrial and intra-atrial conduction times in pediatric patients with non-alcoholic fatty liver disease.

本文引用的文献

1
Association between Gout and Erectile Dysfunction: A Systematic Review and Meta-Analysis.痛风与勃起功能障碍之间的关联:一项系统评价与荟萃分析。
PLoS One. 2016 Dec 30;11(12):e0168784. doi: 10.1371/journal.pone.0168784. eCollection 2016.
2
Clinical outcomes associated with per-operative discontinuation of aspirin in patients with coronary artery disease: A systematic review and meta-analysis.冠状动脉疾病患者围手术期停用阿司匹林的临床结局:一项系统评价和荟萃分析。
Catheter Cardiovasc Interv. 2017 Jun 1;89(7):1168-1175. doi: 10.1002/ccd.26807. Epub 2016 Sep 24.
3
Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).
非酒精性脂肪性肝病患儿的房间隔和房间内传导时间增加。
Eur J Pediatr. 2024 Dec;183(12):5489-5496. doi: 10.1007/s00431-024-05809-8. Epub 2024 Oct 22.
4
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2024 Jan 2;83(1):109-279. doi: 10.1016/j.jacc.2023.08.017. Epub 2023 Nov 30.
5
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
6
A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation.一项基于队列研究的 NAFLD/MAFLD 与新发心房颤动风险的系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2023 Jul 5;14:1160532. doi: 10.3389/fendo.2023.1160532. eCollection 2023.
7
Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes.2型糖尿病患者的非酒精性脂肪性肝病与大血管和微血管并发症风险
J Clin Med. 2022 Feb 12;11(4):968. doi: 10.3390/jcm11040968.
8
Nonalcoholic Fatty Liver Disease Is Associated with Increased Atrial Fibrillation Risk in an Elderly Chinese Population: A Cross-Sectional Study.非酒精性脂肪性肝病与老年中国人心房颤动风险增加相关:一项横断面研究。
Biomed Res Int. 2018 Jul 19;2018:5628749. doi: 10.1155/2018/5628749. eCollection 2018.
9
Nonalcoholic fatty liver disease as a predictor of atrial fibrillation: a systematic review and meta-analysis.非酒精性脂肪性肝病作为心房颤动的预测指标:一项系统评价和荟萃分析。
Postepy Kardiol Interwencyjnej. 2017;13(3):250-257. doi: 10.5114/aic.2017.70198. Epub 2017 Sep 25.
10
Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targets.心房颤动与非酒精性脂肪性肝病的关联:潜在的共同治疗靶点。
Oncotarget. 2017 Jul 24;8(36):60673-60683. doi: 10.18632/oncotarget.19522. eCollection 2017 Sep 1.
非酒精性脂肪性肝病作为中年人群心房颤动的预测指标(OPERA研究)
PLoS One. 2015 Nov 16;10(11):e0142937. doi: 10.1371/journal.pone.0142937. eCollection 2015.
4
Role of inflammation in atrial fibrillation pathophysiology and management.炎症在心房颤动病理生理学及管理中的作用。
Circ J. 2015;79(3):495-502. doi: 10.1253/circj.CJ-15-0138. Epub 2015 Feb 16.
5
Association between non-alcoholic fatty liver disease and autonomic dysfunction in a Chinese population.非酒精性脂肪性肝病与中国人自主神经功能紊乱的相关性。
QJM. 2015 Aug;108(8):617-24. doi: 10.1093/qjmed/hcv006. Epub 2015 Jan 21.
6
Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease.非酒精性脂肪性肝病的非糖尿病男性患者异位脂肪沉积与左心室功能。
Circ Cardiovasc Imaging. 2014 Dec 30;8(1). doi: 10.1161/CIRCIMAGING.114.001979. Print 2015 Jan.
7
Non-alcoholic fatty liver disease: what the clinician needs to know.非酒精性脂肪性肝病:临床医生需要了解的内容。
World J Gastroenterol. 2014 Sep 28;20(36):12956-80. doi: 10.3748/wjg.v20.i36.12956.
8
Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort.肝酶的循环水平与心房颤动的发生率:社区动脉粥样硬化风险队列研究
Heart. 2014 Oct;100(19):1511-6. doi: 10.1136/heartjnl-2014-305756. Epub 2014 Jun 12.
9
Role of the autonomic nervous system in modulating cardiac arrhythmias.自主神经系统在调节心律失常中的作用。
Circ Res. 2014 Mar 14;114(6):1004-21. doi: 10.1161/CIRCRESAHA.113.302549.
10
Heart rate variability findings as a predictor of atrial fibrillation in middle-aged population.心率变异性研究结果作为中年人群心房颤动的预测指标
J Cardiovasc Electrophysiol. 2014 Jul;25(7):719-24. doi: 10.1111/jce.12402. Epub 2014 Apr 9.